Position in ABT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,658,364
+$1,099,377 QoQ
Shares Held
18,276
+333.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1,196
of 2,958 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Neo Ivy Capital Management holds $4,686,677 across 2 Medical Devices names. ABT ranks #2 (35.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
47,310 | $3,028,313 | |
| 2 | ABT |
Abbott Laboratories
This page
|
18,276 | $1,658,364 |
All Filings in ABT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,658,364 | 18,276 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $558,987 | 4,214 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,726,522 | 32,946 | Shares | Sole | 2025-02-18 | |
| 2023-09-30 | $738,771 | 7,628 | Shares | Sole | 2023-11-30 | |
| 2022-09-30 | $100,823 | 1,042 | Shares | Sole | 2022-11-16 | |
| 2022-03-31 | $136,350 | 1,152 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $53,327 | 460 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $37,989 | 317 | Shares | Sole | 2021-10-07 | |
| 2020-03-31 | $48,214 | 611 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||